Comparing two methods of fat grafting for treating scars
Autologous Nanofat Grafting by Injection Versus With Microneedling in Post-burn and Traumatic Atrophic Scars
This study is testing whether injecting fat or using microneedling with fat works better for treating scars from burns or injuries that have been around for over six months.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 18 Years to 60 Years |
| Sex | All |
| Sponsor | Alexandria University Academic / other |
| Locations | 1 site (Alexandria) |
| Trial ID | NCT06566300 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of autologous nanofat injection versus microneedling with autologous nanofat in treating post-burn and traumatic atrophic scars. Participants will receive one of the two interventions to determine which method yields better results in scar management. The study focuses on individuals with scars that have persisted for more than six months and who have not undergone any scar treatments in the past three months.
Who should consider this trial
Good fit: Ideal candidates are males and females aged 18-60 with post-burn or traumatic atrophic scars lasting over six months.
Not a fit: Patients with contractures, hypertrophic or keloid scars, or those with systemic diseases that complicate the procedure may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a more effective treatment option for patients with difficult-to-treat scars.
How similar studies have performed: While there is limited information on similar studies, the use of fat grafting techniques has shown promise in scar treatment, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 1\. Males and females between 18-60 years old. 2. Post-burn or traumatic atrophic scar \> 6 months duration (16). 3. Patients not receiving any treatments for the scar within the past 3 months. Exclusion Criteria: * 1\. Patients with contractures, hypertrophic and keloid scars. 2. Patients with history of bleeding disorders or coagulopathy, or on anticoagulant therpy. 3\. Diabetes and other systemic diseases that may be complicated by the procedure. 4\. Pregnant and lactating females. 5. BMI less than 18.5 6. Patients with scars at the donor site
Where this trial is running
Alexandria
- Alexandria University — Alexandria, Egypt (Recruiting)
Study contacts
- Study coordinator: Dalia I Halwag, PhD, MD
- Email: daliahalwag@gmail.com
- Phone: 0201224489473
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.